Orlistat as a fatty acid synthase inhibitor blocks cell survival mechanism via activating PTEN, which controls PI3K/AKT/MAPK axis in PC3 prostate cancer cells


Aras S., Ozdemir B. S., Arisan E. D., RENCÜZOĞULLARI Ö., ÖZFİLİZ KILBAŞ P., YERLİKAYA P. O., ...More

European Biotechnology Congress, Dubrovnik, Croatia, 25 - 27 May 2017, (Summary Text) identifier

  • Publication Type: Conference Paper / Summary Text
  • Doi Number: 10.1016/j.jbiotec.2017.06.654
  • City: Dubrovnik
  • Country: Croatia
  • Istanbul Kültür University Affiliated: Yes